期刊文献+

左西孟旦对老年慢性充血性心力衰竭患者的疗效及安全性研究 被引量:2

Efficacy and Safety of Levosimendan in Elderly Patients With Chronic Congestive Heart Failure
下载PDF
导出
摘要 目的探讨左西孟旦治疗老年慢性充血性心力衰竭的效果。方法随机将66例慢性充血性心力衰竭老年患者平均分为两组。对照组给予常规治疗,观察组在对照组的基础上行左西孟旦治疗。比较两组临床效果。结果观察组总有效率、心功能指标改善程度等均优于对照组(P<0.05)。结论左西孟旦治疗老年慢性充血性心力衰竭效果显著,安全可靠。 Objective To investigate the effect of levosimendan in the treatment of senile chronic congestive heart failure (CHF). Methods The 66 elderly patients with chronic congestive heart failure were randomly divided into two groups. The control group was given conventional treatment, and the observation group was treated with levosimendan on the basis of the control group. The clinical effects of the two groups were compared. Results The total effective rate and the improvement of cardiac function index in the observation group were better than those in the control group (P〈0.05). Conclusion Levosimendan is effective and safe in the treatment of elderly patients with chronic congestive heart failure.
作者 林涛
出处 《中国继续医学教育》 2017年第10期146-147,共2页 China Continuing Medical Education
关键词 左西孟旦 慢性充血性心力衰竭 临床疗效 levosimendan chronic congestive heart failure clinical efficacy
  • 相关文献

参考文献9

二级参考文献103

  • 1蒋涛,李德才,刘思泰,唐焕君,李健,凌云.1998,2001和2004年绵阳市慢性心力衰竭住院患者药物治疗动态分析[J].四川医学,2006,27(6):598-600. 被引量:19
  • 2NG TM.Levosimendan,a new calcium sensitizing inotropoe for heart failure[J].Pharmacotherapy,2004,24(10):1366-1384.
  • 3Jan A,Murphy NF,O'Loughlin C,et al.Profiling B-type natriuretic peptide in a stable heart failure population:a valuable adjunct to care[J].Ir J Med Sci,2011,180(2):355-362.
  • 4Moxon JV,Theophilus I,et al.Further evidence to support a role for urocortin 2 in heart failure[J].Anadolu Kardiyol Derg,2012,12(2):121-122.
  • 5Topal E,Yagmur J,Otlu B,et al.Relationship of urocortin-2 with systolic and diastolic functions and coronary artery disease:an observational study[J].Anadolu Kardiyol Derq,2012,12(2):115-120.
  • 6MEBAZAA A, NIEMINEN M S, PACKER M, et at. SURVIVE Investigators. Levosimendan vs dobu- tamine for patients with acute deeompensated heart failure: the SURVIVE Randomized Trial[J]. JAMA, 2007,297:1883--1891.
  • 7FLEVARI P, PARISSIS J T, LEFTHER1OTIS D, et al. Effect of levosimendan on ventricular arrhyth- mias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy[J]. Am J Car- diol, 2006,98 : 1641 -- 1645.
  • 8CHOGY, SONGJ K, PARKWJ, et al. Mechani- cal dyssynchrony assessed by tissue Doppler imaging is a powerful predictor of mortality in congestive heart failure with normal QRS duration[J]. J Am Coll Car- diol,2005,46:2237--2243.
  • 9FOSBOL E L, SEIBAEK M, BRENDORP B, et al. Danish Investigations and Arrhythmia on Dofetilide (Diamond) Study Group. Prognostic importance of change in QRS duration over time associated with left ventrieular dysfunction in patients with congestive heart failure., the D IAMOND study[J]. J Card Fail, 2008,14:850--855.
  • 10NG T M. Levosimendan, a new calcium-sensitizing inotropoe for heart failure [J]. Pharmacotherapy, 2004,24:1366-- 1384.

共引文献101

同被引文献20

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部